Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis.
Multiple sclerosis patients treated with intramuscular IFN-β-1a autoinjector in a real-world setting: prospective evaluation of treatment persistence, adherence, quality of life and satisfaction.
European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTA™ (Daclizumab High-Yield Process) for Treatment of MS
Surveillance and medical therapy following endovascular treatment of chronic cerebrospinal venous insufficiency.
[The role of brain glucose metabolism in the development of cognitive dysfunctions in patients with remitting and secondary-progressive multiple sclerosis.]
Journal Club: Intrathecal effects of daclizumab treatment of multiple sclerosis.
Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis.
Psychiatric disorders in patients with multiple sclerosis.
[Factorial structure of the dysexecutive questionnaire in a sample of the Spanish population with acquired brain injury and memory deficit complaints].
The Transcription Factor IRF8 Activates Integrin-Mediated TGF-β Signaling and Promotes Neuroinflammation.
Electromagnetic Field Stimulation Potentiates Endogenous Myelin Repair by Recruiting Subventricular Neural Stem Cells in an Experimental Model of White Matter Demyelination.
Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone.
[Epidemiology and clinical assessment of spasticity in multiple sclerosis].
[Autoimmune hepatitis in a patient with multiple sclerosis under treatment with glatiramer acetate].
Visual evoked potentials in early diagnosis of demyelinating diseases - a case report of Devic's disease.
Galanin Transgenic Mice with Elevated Circulating Galanin Levels Alleviate Demyelination in a Cuprizone-Induced MS Mouse Model.
Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model.
The Symptom Inventory Disability-Specific Short Forms for Multiple Sclerosis: Construct Validity, Responsiveness, and Interpretation.
Extreme Stability of Chitotriosidase in Cerebrospinal Flulid makes it a Suitable Marker for Microglial Activation in Clinical Trials.
Prognostic indicators for long-term disability in multiple sclerosis patients.
Occupational Exposure and Risk of Central Nervous System Demyelination.
Picornavirus infection leading to immunosuppression.
Physical fitness assessment in multiple sclerosis patients: A controlled study.
Combined oral contraceptives: health benefits beyond contraception.
Antinuclear antibodies in pediatric acquired demyelinating diseases of the central nervous system.

Pages